Although no subjects with severe AATD deficiency were detected in this study, we found six out of 187 (5%) subjects positive for so called “intermediate genetic AAT deficiency” [mean (SD) AAT level: 0.85 g/L (0.17)]. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.